Differences in the levels of molecular markers, including ER, PR, HER2 [22] and epithelial-to-mesenchymal transition-related markers [23], between primary breast cancers and both lymph nodes and distant metastases have been frequently demonstrated in previous studies. The gene discussed is ERBB2; the disease is breast carcinoma.